ProAmpac Celebrates Trio of Honors at 2024 AmeriStar Awards
5.9.2024 18:45:00 EEST | Business Wire | Press release
ProAmpac, a leader in flexible packaging and material science, is thrilled to announce its recognition at the 2024 AmeriStar Awards, securing two wins in the Sustainable Packaging category and contributing to a third recognition for an innovative e-commerce solution. The accolades showcase ProAmpac's dedication to sustainability and innovation with the RAP Sandwich Wedge for Sammi's; ProActive Recyclable RP-1000 Paper Series for Marks & Spencer's organic potatoes; and the insulated paper bag known as ProActive Recyclable FiberCool.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905477309/en/
Sammi's RAP Sandwich Wedge (Photo: Business Wire)
"The recognition by AmeriStar reflects our relentless pursuit of innovative and sustainable packaging solutions," said Chad Murdock, president of the fiber division at ProAmpac. "We're honored to have our efforts acknowledged, especially as we continue to advance in areas like the fiberization of packaging that contribute to a more circular economy."
Developed for Sammi’s grab-and-go sandwiches, the high-barrier RAP Sandwich Wedge, with a premium shelf appearance, utilizes a fiber-based carton board with a transparent window. This innovative solution employs modified atmosphere packaging, optimizing product preservation and visibility while maintaining very low oxygen levels for extended shelf life and decreased food waste.
Designed for Marks & Spencer’s organic potatoes, ProAmpac’s second award-winning innovation, the ProActive Recyclable® RP-1000 Paper Series, offers superior robustness and a premium natural look for packing organic potatoes. This fully recyclable packaging has premium sealant technology for running at rate on high-speed form-fill-seal equipment and is curbside recyclable in the UK, while also being FSC-certified for responsible sourcing.
"Our technical team is at the forefront of fiber packaging innovation across diverse markets," said Lynsey Maddison, director of product development at ProAmpac. "We are committed to advancing these technologies to help our customers achieve more sustainable packaging solutions. As we continue to explore new applications and improvements, our goal remains to drive impactful, eco-friendly advancements in the industry.”
In addition to these two awards, ProAmpac contributed to a win in the Packaging that Saves Food category with the ProActive Recyclable FiberCool, an insulated paper bag for e-commerce delivery. This fiber-based, curbside-recyclable solution replaces a bulky traditional multi-package system, reducing packaging weight and drastically enhancing thermal retention. “Our work on FiberCool exemplifies how we can innovate to meet the growing demand for sustainable packaging without compromising on performance,” said Ray Recchia, global innovation manager at ProAmpac. “By improving thermal insulation, we help reduce food spoilage and waste, giving customers more flexibility with their groceries after delivery,” adds Recchia.
As ProAmpac continues to innovate, it remains dedicated to enhancing sustainability and product performance. For more information on ProAmpac’s award-winning packaging solutions, visit ProAmpac.com or contact Marketing@ProAmpac.com.
About ProAmpac
ProAmpac is a leading global flexible packaging company with a comprehensive product offering, providing creative packaging solutions, industry-leading customer service and award-winning innovation to a diverse global marketplace. ProAmpac’s approach to sustainability – ProActive Sustainability® – provides innovative sustainable flexible packaging products to help our customers achieve their sustainability goals. We are guided in our work by five core values that are the basis for our success: Integrity, Intensity, Innovation, Involvement and Impact. Cincinnati-based ProAmpac is owned by Pritzker Private Capital along with management and co-investors. For more information, visit ProAmpac.com or contact Media@ProAmpac.com.
About Pritzker Private Capital
Pritzker Private Capital partners with middle-market companies based in North America with leading positions in the manufactured products and services sectors. The firm's differentiated, long duration capital base allows for efficient decision-making, broad flexibility with transaction structure and investment horizon, and alignment with all stakeholders. Pritzker Private Capital builds businesses for the long term and is an ideal partner for entrepreneur- and family-owned companies. Pritzker Private Capital is a signatory to the United Nations Principles for Responsible Investment (PRI). For more information, visit PPCPartners.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905477309/en/
Contacts
Whitney Miles
ProAmpac
(617) 721-7040
Whitney.Miles@ProAmpac.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 16:00:00 EEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 15:00:00 EEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 15:00:00 EEST | Press release
The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 500 million AGR uranium pellets and 222,000 AGR grids – which is equivalent to burning over 685 tonnes of coal, avoiding the emission of nearly 3 billion tonnes of CO2. Sp
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom